熱門資訊> 正文
Atara Biotherapeutics公开募股定价1600万美元
2025-05-15 20:42
- Atara Biotherapeutics (NASDAQ:ATRA) announced the pricing of an offering of 834,237 shares of common stock at $6.61/share and pre-funded warrants to purchase 1.59M shares of common stock at $6.6099/pre-funded warrant share in an underwritten registered direct offering.
- The pre-funded warrants will be immediately exercisable upon issuance. The offering is expected to close on or about May 16, 2025.
- The gross proceeds from the offering are expected to be $16M.
- Atara currently intends to use the net proceeds from the offering to fund its ongoing activities required to achieve biologics license application approval for tab-cel, and for working capital and general corporate purposes.
- ATRA shares up nearly 3% premarket on Thursday.
- Source: Press release
More on Atara Biotherapeutics
- Atara Biotherapeutics to reduce workforce by 30%
- Seeking Alpha’s Quant Rating on Atara Biotherapeutics
- Historical earnings data for Atara Biotherapeutics
- Financial information for Atara Biotherapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
